Pfizer Cancer Drug Way Too Expensive, Biden Told
The U.S. government is being asked yet again to use patent laws to lower the price of a prostate cancer drug that was developed at UCLA and is being sold by...To view the full article, register now.
Already a subscriber? Click here to view full article